The wildest, scariest, indisputable truth about AI's large language models is that the companies building them don't know exactly why or how they work.
A U.S.-based biotech company has unveiled a new IVF option that allows parents to select embryos based on genetic markers tied to health and longevity. DNA testing and analysis company Nucleus Genomics has announced the world's first genetic optimization software that 'helps parents pursuing IVF see and understand the complete genetic profile of each of their embryos.'
Under the Trump administration, the Food and Drug Administration is eagerly embracing artificial intelligence tools that staff members are reportedly calling rushed, buggy, overhyped, and inaccurate.
Aveanna Healthcare Holdings has finalized its acquisition of Thrive Skilled Pediatric Care. Thrive SPC operates 23 locations across seven states and provides skilled private duty nursing, pediatric therapy, and services from licensed health aides and certified nurse assistants. This strategic acquisition broadens Aveanna's operational footprint in its current markets and introduces its specialized care services into two additional states, enhancing their overall service capabilities and market presence.
DispatchHealth has completed its merger with Medically Home, creating a healthcare platform that delivers complex care directly to patients' homes. The union of these two entities aims to reduce unnecessary emergency room and hospital visits, offering a more adaptable and cost-effective solution for broadening access.
At only 14 years old, Siddarth Nandyala has created a heart disease detection app that can identify early signs of cardiovascular issues in seconds. The app is called Circadian AI, and it could be a powerful tool for early intervention, especially in regions where access to healthcare is limited.